Abstract
Transcription factors ThPOK and Runx3 regulate the differentiation of “helper” CD4+ and “cytotoxic” CD8+ T cell lineages respectively, inducing single positive (SP) T cells that enter the periphery with the expression of either the CD4 or CD8 co-receptor. Despite the expectation that these cell fates are mutually exclusive and that mature CD4+CD8+ double positive (DP) T cells are present in healthy individuals and augmented in the context of disease, yet their molecular features and pathophysiologic role are disputed. Here, we show DP T cells in murine and human tumors as a heterogenous population originating from SP T cells which re-express the opposite co-receptor and acquire features of the opposite cell type’s phenotype and function following TCR stimulation. We identified distinct clonally expanded DP T cells in human melanoma and lung cancer by scRNA sequencing and demonstrated their tumor reactivity in cytotoxicity assays. Our findings indicate that antigen stimulation induces SP T cells to differentiate into DP T cell subsets gaining in polyfunctional characteristics.
Funding Information
  • National Institutes of Health (P30 CA008748)
  • National Cancer Institute (NCI R01 CA056821)
  • Swim Across America
  • Ludwig Institute for Cancer Research
  • Memorial Sloan Kettering
  • Cancer Research Institute
  • Parker Institute for Cancer Immunotherapy
  • Cancer Immunology Translational Cancer Research (SU2C-AACR-DT1012)
  • Cancer Research Institute-Stand Up 2 Cancer
  • John Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy
  • Bristol-Myers Squibb International Immuno-Oncology Network
  • National Cancer Institute (P30 CA08748)
  • Cycle for Survival
  • Marie-Josée and Henry R. Kravis Center for Molecular Oncology

This publication has 43 references indexed in Scilit: